Fulminant Hepatic Failure

Overview

Journal West J Med

Specialty General Medicine

Date 1988 Nov 1

PMID 3074559

Authors

R J Yanda

Affiliations

Soon will be listed here.

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

References

TREY C, Davidson C . The management of fulminant hepatic failure. Prog Liver Dis. 1970; 3:282-98. View

OGrady J, Gimson A, OBrien C, Pucknell A, Hughes R, Williams R . Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988; 94(5 Pt 1):1186-92. DOI: 10.1016/0016-5085(88)90011-x. View

Redeker A, SCHWEITZER I, YAMAHIRO H . Letter: Randomization of corticosteroid therapy in fulminant hepatitis. N Engl J Med. 1976; 294(13):728-9. DOI: 10.1056/NEJM197603252941315. View

Weston M, Talbot I, Horoworth P, Mant A, Capildeo R, Williams R . Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J. 1976; 38(11):1179-88. PMC: 483152. DOI: 10.1136/hrt.38.11.1179. View

MacDougall B, Bailey R, Williams R . H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977; 1(8012):617-9. DOI: 10.1016/s0140-6736(77)92055-4. View

Horney J, GALAMBOS J . The liver during and after fulminant hepatitis. Gastroenterology. 1977; 73(4 Pt 1):639-45. View

Tygstrup N, Ranek L . Fulminant hepatic failure. Clin Gastroenterol. 1981; 10(1):191-208. View

Gimson A, Braude S, Mellon P, Canalese J, Williams R . Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982; 2(8300):681-3. DOI: 10.1016/s0140-6736(82)90711-5. View

Wyke R, Canalese J, Gimson A, Williams R . Bacteraemia in patients with fulminant hepatic failure. Liver. 1982; 2(1):45-52. DOI: 10.1111/j.1600-0676.1982.tb00177.x. View

10.

Dienstag J . Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983; 85(2):439-62. View

11.

Gimson A, Tedder R, White Y, Eddleston A, Williams R . Serological markers in fulminant hepatitis B. Gut. 1983; 24(7):615-7. PMC: 1420029. DOI: 10.1136/gut.24.7.615. View

12.

Rizzetto M . The delta agent. Hepatology. 1983; 3(5):729-37. DOI: 10.1002/hep.1840030518. View

13.

Gimson A, White Y, Eddleston A, Williams R . Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983; 24(12):1194-8. PMC: 1420253. DOI: 10.1136/gut.24.12.1194. View

14.

Govindarajan S, Chin K, Redeker A, Peters R . Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984; 86(6):1417-20. View

15.

Rakela J, Lange S, Ludwig J, Baldus W . Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc. 1985; 60(5):289-92. DOI: 10.1016/s0025-6196(12)60534-5. View

16.

Fraser C, Arieff A . Hepatic encephalopathy. N Engl J Med. 1985; 313(14):865-73. DOI: 10.1056/NEJM198510033131406. View

17.

Iwatsuki S, Esquivel C, Gordon R, Shaw Jr B, Starzl T, Shade R . Liver transplantation for fulminant hepatic failure. Semin Liver Dis. 1985; 5(4):325-8. PMC: 2975970. DOI: 10.1055/s-2008-1040628. View

18.

Ede R, Gimson A, Bihari D, Williams R . Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986; 2(1):43-51. DOI: 10.1016/s0168-8278(86)80007-1. View

19.

Gimson A, OGrady J, Ede R, Portmann B, Williams R . Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986; 6(2):288-94. DOI: 10.1002/hep.1840060222. View

20.

Jones E, Schafer D . Hepatic encephalopathy: a neurochemical disorder. Prog Liver Dis. 1986; 8:525-40. View